GDNF in treatment of Parkinson's disease: response to editorial.
Richard D
RD
Penn
Arif
A
Dalvi
John
J
Slevin
Byron
B
Young
Don
D
Gash
Greg
G
Gerhardt
Michael
M
Hutchinson
D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D028701:Patient Rights
D051100:Glial Cell Line-Derived Neurotrophic Factor